David Cole to Neoplasm Staging
This is a "connection" page, showing publications David Cole has written about Neoplasm Staging.
Connection Strength
0.305
-
Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg. 2004 Jun; 239(6):828-37; discussion 837-40.
Score: 0.047
-
Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel. J Am Coll Surg. 1998 Jul; 187(1):9-16.
Score: 0.031
-
Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients. Am Surg. 1998 Jun; 64(6):539-43; discussion 543-4.
Score: 0.031
-
Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection. Semin Oncol. 1996 Dec; 23(6):719-24.
Score: 0.028
-
Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model. J Hepatol. 2017 01; 66(1):75-85.
Score: 0.028
-
The impact of lymph node disease in extremity soft-tissue sarcomas: a population-based analysis. Am J Surg. 2013 Sep; 206(3):289-95.
Score: 0.022
-
Melanoma of the external ear. J Surg Oncol. 1992 Jun; 50(2):110-4.
Score: 0.021
-
Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort study. Ann Surg Oncol. 2010 Oct; 17 Suppl 3:312-20.
Score: 0.018
-
The expression ratio of Map7/B2M is prognostic for survival in patients with stage II colon cancer. Int J Oncol. 2008 Sep; 33(3):579-84.
Score: 0.016
-
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother. 2009 Jan; 58(1):49-59.
Score: 0.016
-
Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study. Surgery. 2005 Sep; 138(3):474-81.
Score: 0.013
-
An innovative microarray strategy identities informative molecular markers for the detection of micrometastatic breast cancer. Clin Cancer Res. 2005 May 15; 11(10):3697-704.
Score: 0.013
-
Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]. J Mol Diagn. 2003 Nov; 5(4):237-42.
Score: 0.011
-
The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma. Br J Cancer. 2000 Jul; 83(1):16-21.
Score: 0.009